These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 20387134)

  • 21. Heart failure patients with prediabetes and newly diagnosed diabetes display abnormalities in myocardial metabolism.
    Nielsen R; Jorsal A; Iversen P; Tolbod L; Bouchelouche K; Sørensen J; Harms HJ; Flyvbjerg A; Bøtker HE; Wiggers H
    J Nucl Cardiol; 2018 Feb; 25(1):169-176. PubMed ID: 27473218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical significance of quantitative assessment of glucose utilization in patients with ischemic cardiomyopathy.
    Ko KY; Wang SY; Yen RF; Shiau YC; Hsu JC; Tsai HY; Lee CL; Chiu KM; Wu YW
    J Nucl Cardiol; 2020 Feb; 27(1):269-279. PubMed ID: 30109593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation between myocardial blood flow and fasting glucose metabolism in ischemic heart disease. Quantitative assessment by nitrogen-13 ammonia and fluorine-18 fluorodeoxyglucose positron emission tomography.
    Watanabe T; Okazaki O; Akutsu Y; Yamanaka H; Michihata T; Katagiri T; Harumi K
    Jpn Heart J; 1998 May; 39(3):275-85. PubMed ID: 9711179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood flow, flow reserve, and glucose utilization in viable and nonviable myocardium in patients with ischemic cardiomyopathy.
    Zhang X; Schindler TH; Prior JO; Sayre J; Dahlbom M; Huang SC; Schelbert HR
    Eur J Nucl Med Mol Imaging; 2013 Apr; 40(4):532-41. PubMed ID: 23287994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancement of myocardial [fluorine-18]fluorodeoxyglucose uptake by a nicotinic acid derivative.
    Knuuti MJ; Yki-Järvinen H; Voipio-Pulkki LM; Mäki M; Ruotsalainen U; Härkönen R; Teräs M; Haaparanta M; Bergman J; Hartiala J; Wegelius U; Nuutila P
    J Nucl Med; 1994 Jun; 35(6):989-98. PubMed ID: 8195886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sex-specific differences in myocardial glucose metabolic rate in non-diabetic, pre-diabetic and type 2 diabetic subjects.
    Succurro E; Vizza P; Cicone F; Cassano V; Massimino M; Giofrè F; Fiorentino TV; Perticone M; Sciacqua A; Guzzi PH; Veltri P; Andreozzi F; Cascini GL; Sesti G
    Cardiovasc Diabetol; 2024 Apr; 23(1):144. PubMed ID: 38671460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced stimulation of glucose uptake by insulin increases exercise-stimulated glucose uptake in skeletal muscle in humans: studies using [15O]O2, [15O]H2O, [18F]fluoro-deoxy-glucose, and positron emission tomography.
    Nuutila P; Peltoniemi P; Oikonen V; Larmola K; Kemppainen J; Takala T; Sipilä H; Oksanen A; Ruotsalainen U; Bolli GB; Yki-Järvinen H
    Diabetes; 2000 Jul; 49(7):1084-91. PubMed ID: 10909962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regional myocardial blood flow and glucose utilization during fasting and physiological hyperinsulinemia in humans.
    Iozzo P; Chareonthaitawee P; Di Terlizzi M; Betteridge DJ; Ferrannini E; Camici PG
    Am J Physiol Endocrinol Metab; 2002 May; 282(5):E1163-71. PubMed ID: 11934683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incremental prognostic value of left ventricular function by myocardial ECG-gated FDG PET imaging in patients with ischemic cardiomyopathy.
    Santana CA; Shaw LJ; Garcia EV; Soler-Peter M; Candell-Riera J; Grossman GB; Krawczynska EG; Faber TL; Ribera A; Vaccarino V; Halkar R; Di Carli MF
    J Nucl Cardiol; 2004; 11(5):542-50. PubMed ID: 15472639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myocardial glucose uptake in patients with NIDDM and stable coronary artery disease.
    Mäki M; Nuutila P; Laine H; Voipio-Pulkki LM; Haaparanta M; Solin O; Knuuti JM
    Diabetes; 1997 Sep; 46(9):1491-6. PubMed ID: 9287051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myocardial pre-synaptic sympathetic function correlates with glucose uptake in the failing human heart.
    Mongillo M; John AS; Leccisotti L; Pennell DJ; Camici PG
    Eur J Nucl Med Mol Imaging; 2007 Aug; 34(8):1172-7. PubMed ID: 17294189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic performance of quantitative PET tools for stratification of patients with ischemic cardiomyopathy undergoing myocardial viability assessment.
    Santana CA; Faber TL; Soler-Peter M; Sanyal R; Esteves FP; Ornelas M; Folks RD; Verdes L; Santana LF; Candell-Riera J; Garcia EV
    Nucl Med Commun; 2008 Nov; 29(11):970-81. PubMed ID: 18836375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The utility of
    Moody JB; Hiller KM; Lee BC; Poitrasson-Rivière A; Corbett JR; Weinberg RL; Murthy VL; Ficaro EP
    J Nucl Cardiol; 2019 Apr; 26(2):374-386. PubMed ID: 30809755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased glycolytic metabolism in non-compaction cardiomyopathy by 18F-fluoro-2-deoxyglucose positron emission tomography: new insights into pathophysiological mechanisms and clinical implications.
    Tavares de Melo MD; Giorgi MCP; Assuncao AN; Dantas RN; Araujo Filho JA; Parga Filho JR; Bierrenbach ALS; de Lima CR; Soares J; Meneguetti JC; Mady C; Hajjar LA; Kalil Filho R; Bocchi EA; Salemi VMC
    Eur Heart J Cardiovasc Imaging; 2017 May; 18(8):915-921. PubMed ID: 28379356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin resistance in patients with cardiac hypertrophy.
    Paternostro G; Pagano D; Gnecchi-Ruscone T; Bonser RS; Camici PG
    Cardiovasc Res; 1999 Apr; 42(1):246-53. PubMed ID: 10435017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-diagnostic
    Valentin RC; Farag A; Hage FG; Bhambhvani P
    J Nucl Cardiol; 2019 Oct; 26(5):1775-1776. PubMed ID: 30168028
    [No Abstract]   [Full Text] [Related]  

  • 37. Relation of end-diastolic wall thickness and the residual rim of viable myocardium by magnetic resonance imaging to myocardial viability assessed by fluorine-18 deoxyglucose positron emission tomography.
    Kühl HP; van der Weerdt A; Beek A; Visser F; Hanrath P; van Rossum A
    Am J Cardiol; 2006 Feb; 97(4):452-7. PubMed ID: 16461035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pre-clinical myocardial metabolic alterations in chronic kidney disease.
    Fink JC; Lodge MA; Smith MF; Hinduja A; Brown J; Dinits-Pensy MY; Dilsizian V
    Cardiology; 2010; 116(3):160-7. PubMed ID: 20606430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myocardial glucose uptake in patients with insulin-dependent diabetes mellitus assessed quantitatively by dynamic positron emission tomography.
    vom Dahl J; Herman WH; Hicks RJ; Ortiz-Alonso FJ; Lee KS; Allman KC; Wolfe ER; Kalff V; Schwaiger M
    Circulation; 1993 Aug; 88(2):395-404. PubMed ID: 8339403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delayed response of insulin-stimulated fluorine-18 deoxyglucose uptake in glucose transporter-4-null mice hearts.
    Simões MV; Egert S; Ziegler S; Miyagawa M; Reder S; Lehner T; Nguyen N; Charron MJ; Schwaiger M
    J Am Coll Cardiol; 2004 May; 43(9):1690-7. PubMed ID: 15120832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.